Ondine Appoints Peel Hunt as Broker
Ondine appoints Peel Hunt as broker and joint financial adviser, effective immediately.
Select text to share a quote on X · sign in to keep highlights & notes in your OBI notes
Ondine Biomedical Inc. (AIM: OBI), a Canadian life sciences company pioneering light-activated antimicrobial treatments, announces the appointment of Peel Hunt LLP as the Company's broker and joint financial adviser, effective immediately.
Carolyn Cross, CEO of Ondine Biomedical, commented:
"We are pleased to be working with Peel Hunt, a firm with deep expertise in supporting growth-stage companies in the healthcare sector. Their strong investor network and integrated advisory approach will help us expand our shareholder base and strengthen investor support as we continue to grow our business globally."
About Peel Hunt
Peel Hunt is a leading UK investment bank that specialises in supporting mid-cap and growth companies. It provides integrated investment banking advice and services to UK corporates, including equity capital markets, private capital markets, M&A, debt advisory, investor relations and corporate broking. The Company's joined up approach combines these services with expert research and distribution and an execution services hub that provides liquidity to the UK capital markets, delivering value to global institutions and trading counterparties alike. The Company is admitted to trading on AIM (LON: PEEL) and has offices in London, New York and Copenhagen.
About Ondine Biomedical Inc.
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.